股腘动脉感染性原生动脉瘤:系统综述与汇总分析
该系统综述汇总1990年至2024年7月发表的82项研究、368例患者共382个股腘动脉感染性原生动脉瘤(INA-FPs),其中81.3%为静脉吸毒者(IVDU)。IVDU患者更年轻、病变更常累及股总动脉且1年死亡率更低;金黄色葡萄球菌最常见(39%)。IVDU患者以结扎为主(89.3%),非IVDU以旁路术为主(69.6%);旁路术再出血风险为结扎的5倍且50%致命,结扎后跛行风险为旁路术的4倍但截肢率相当。
要点
- INA-FPs罕见,81.3%发生于IVDU患者,股总动脉最常受累(79.8%)。
- IVDU患者1年死亡率低于非IVDU(2.9% vs 17.3%),但结扎后跛行风险更高(24% vs 6%)。
- 旁路术再出血风险为结扎的5倍且50%致命,需多学科个体化权衡血运重建与致命出血风险。
核心结论
- INA-FPs罕见报道,IVDU与非IVDU患者在特征、手术方式和结局上存在显著差异。
- 需个体化多学科团队管理,仔细权衡血运重建获益与致命出血风险。
研究设计与样本
- 系统检索PubMed、ScienceDirect、Embase和Cochrane Library,纳入1990年至2024年7月发表的研究,遵循PRISMA指南。
- 共纳入82项研究、368例患者、382个INA-FPs。
主要发现
- INA-FPs位于股总动脉305例(79.8%)、股深动脉4例(1.0%)、股浅动脉45例(11.8%)、腘动脉28例(7.3%)。
- IVDU患者299例(81.3%),非IVDU患者69例(18.7%)。
- IVDU患者更年轻(平均39岁 vs 65岁;P < .001),更常累及股总动脉(93.2% vs 23.3%;P < .001),1年死亡率更低(2.9% vs 17.3%;P < .001)。
- 最常见病原体为金黄色葡萄球菌(39%)。
- IVDU患者最常行结扎术(89.3%),非IVDU患者最常行旁路术(69.6%)。
临床怎么用
- 对INA-FPs患者应评估IVDU状态,因其影响病变部位、治疗选择和预后。
- IVDU患者多采用结扎术,非IVDU患者多采用旁路术,但需权衡旁路术再出血风险与结扎后跛行风险。
- 多学科团队管理应个体化平衡血运重建获益与致命出血风险。
局限性
- 关于多学科团队管理和抗菌治疗的详细信息缺失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Infective native aneurysms of the femoropopliteal arteries (INA-FPs) are rare and mostly reported in patients with a history of intravenous drug use (IVDUs). This study aimed to summarize all cases of INA-FPs presented in the literature, to describe patient characteristics, microbiology, treatments and outcomes, and compare IVDU with non-IVDU patients. METHODS: A systematic search of PubMed, ScienceDirect, Embase, and the Cochrane Library was done for studies published between 1990 and July 2024. The study followed the PRISMA guidelines and articles were scrutinized regarding patient characteristics, anatomical segment, etiology, microbiology, treatment modalities, and outcomes. RESULTS: Eighty-two studies comprising 368 patients with 382 INA-FPs were included. INA-FPs were located in the common femoral artery (CFA) in 305 cases (79.8%), the deep femoral artery in 4 (1.0%), the superficial femoral artery in 45 (11.8%), and the popliteal artery in 28 (7.3%). These INA-FPs developed in 299 IVDU (81.3%) and in 69 non-IVDU patients (18.7%). IVDU patients were younger (mean age 39 years vs 65 years; P < .001), more frequently had common femoral artery involvement (93.2% vs 23.3%; P < .001), and had lower 1-year mortality rates (2.9% vs 17.3%; P < .001). The most common pathogen was Staphylococcus aureus (39%). Details on multidisciplinary team management and antimicrobial therapy were missing. Ligation was the most performed treatment in IVDU patients (89.3%), whereas bypass was the most used in non-IVDUs (69.6%). In the entire cohort, bypass was associated with a five-fold increase in rebleeding risk compared with ligation (P < .001), and 50% were fatal. Ligation demonstrated a four-fold increased risk of claudication compared with bypass (24% vs 6%), but amputation rates were equal. CONCLUSIONS: INA-FPs are rarely reported, with significant differences in patient characteristics, surgical management, and outcomes between IVDU and non-IVDU patients. These findings underscore the need for tailored multidisciplinary team management that carefully balances the benefits of revascularization against the risks of fatal bleeding.
引用
- Smet N, Bérard X, Ljungquist O, et al. Infective native aneurysms of the femoropopliteal arteries: A systematic review and pooled analysis. J Vasc Surg. 2025. PMID: 40835161. doi:10.1016/j.jvs.2025.08.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。